Methotrexate vs placebo
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
Methotrexate may leads to higher treatment responsea(up to 6 months) compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Methotrexate showed no clear difference in participant global assessment of well‐being(up to 6 months) compared with placebo (low certainty).
Methotrexate showed no clear difference in serious adverse events(up to 6 months) compared with placebo (low certainty).
Methotrexate showed no clear difference in withdrawals due to adverse events (up to 6 months) compared with placebo (low certainty).
Methotrexate may leads to higher disease response compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Methotrexate showed no clear difference in serious adverse events (SAEs) assessed by number of events compared with placebo (low certainty).
Methotrexate showed no clear difference in withdrawals due to adverse events (WAEs) assessed by number of events compared with placebo (low certainty).